Abstract
Dendritic cells (DCs) play an important role in initiating and directing T-cells towards immunity or tolerance. An important aim of emerging immunosuppressive strategies is to ensure that antigen is perceived in a 'tolerogenic context'. This would have obvious benefit in minimising the need for long-term drug maintenance in organ transplantation, hypersensitivity and autoimmune diseases. Here we review the biology of the interplay between the DC and T-cell, with a specific focus on therapeutic drugs targeting molecules that effect their interaction and function. © 2005 Bentham Science Publishers Ltd.
Original language | English |
---|---|
Pages (from-to) | 397-411 |
Number of pages | 14 |
Journal | Current Drug Targets: Immune, Endocrine and Metabolic Disorders |
Volume | 5 |
Issue number | 4 |
Publication status | Published - Dec 2005 |
Keywords
- Antibodies
- Dendritic cells
- Immunological synapse
- Pharmacological agents
- T cells
- Tolerance